Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Dialysability in Severe Renal Impairment
NCT00656799Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2008
- Primary completion
- Jul 2009
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Merck & Co.. Started Apr 2008; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT00656799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656799.